• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Institutional Site Licenses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Fact Sheet

Articles Tagged with ''Fact Sheet''

Fact Sheet

Oxybates (Lumryz, Xyrem, Xywav) Fact Sheet [G]

.
January 1, 2026
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Melatonin is a hormone secreted by the pineal gland that helps regulate the sleep-wake cycle.



Read More
Fact Sheet

Dopamine Agonists (Mirapex, Neupro, Requip, Sinemet) Fact Sheet [G]

January 1, 2026
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dopamine agonists are effective first-line agents for RLS though rates of problematic impulsive or compulsive behaviors can be high.


Read More
Fact Sheet

Armodafinil (Nuvigil) Fact Sheet [G]

January 1, 2026
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Armodafinil is an effective wake-promoting agent with some potential for abuse and for drug interactions. 


Read More
Fact Sheet

Vitamin D Fact Sheet [G]

January 1, 2026
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Vitamin D supplementation may be beneficial in depression, but the evidence is strongest for those with low vitamin D levels. Make sure patients take adequate doses, in the range of 1000–5000 IU daily.


Read More
Fact Sheet

St. John’s Wort Fact Sheet [G] for General Psychiatry

January 1, 2026
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

St. John’s wort may be considered for short-term treatment of mild to moderate depression, especially in patients seeking natural options. However, its extensive drug interaction profile limits broader clinical use.



Read More
Fact Sheet

Melatonin Fact Sheet [G]

January 1, 2026
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Melatonin is a hormone secreted by the pineal gland that helps regulate the sleep-wake cycle.


Read More
Fact Sheet

Zolpidem (Ambien, Edluar, Intermezzo, Zolpimist) Fact Sheet [G]

January 1, 2026
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Ambien is the original Z-drug, having been initially FDA approved in 1992.


Read More
Fact Sheet

Zaleplon (Sonata) Fact Sheet [G]

January 1, 2026
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Zaleplon is the only sleeping pill that can be taken at 3 or 4 am without causing functional impairment when the patient gets out of bed a few hours later.


Read More
Fact Sheet

Doxepin (Silenor) Fact Sheet [G]

January 1, 2026
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Low-dose doxepin is effective for sleep maintenance insomnia and is generally well tolerated at hypnotic doses, with minimal anticholinergic effects compared to higher antidepressant doses.


Read More
Fact Sheet

Buspirone (BuSpar) Fact Sheet [G]

January 1, 2026
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Buspirone is a non-benzodiazepine anxiolytic that is not habit-forming and does not cause sedation, but it takes time to work and is less effective for acute anxiety.


Read More
Previous 1 2 … 11 12 13 14 15 16 17 18 19 … 56 57 Next
Try The New AskCarlat AI

Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

Available In The Carlat Toolkit
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • MFB8e_SpiralCover.png

    Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

    Updated 2026 prescriber's guide.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2782224449.jpg
    General Psychiatry

    Gender Affirming Care: Fall of the House of Hopkins

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.